```html

Apple‑Jelly Skin (Necrobiosis Lipoidica)

What is Apple‑Jelly Skin (Necrobiosis Lipoidica)?

Necrobiosis lipoidica (NL) is a chronic inflammatory skin disorder most often recognized by its characteristic “apple‑jelly” appearance—a translucent, yellow‑brown plaque with a shiny surface that may have a central area of atrophy. The lesions are usually located on the shins, but they can appear on the forearms, torso, or face. While the exact cause is unknown, NL is thought to involve an abnormal immune response that damages collagen and blood vessels in the skin. The condition is relatively rare, affecting about 0.3 % of the population, and is seen more frequently in women and in people with diabetes mellitus (especially type 1) [1][2].

Common Causes

Necrobiosis lipoidica is not caused by a single factor; rather, it occurs in the context of several underlying conditions or triggers. The most frequently reported associations are:

• Type 1 diabetes mellitus – present in up to 65 % of NL cases.
• Other forms of diabetes (type 2) – less common but still relevant.
• Autoimmune disorders – such as rheumatoid arthritis, systemic lupus erythematosus, and thyroid disease.
• Granulomatous diseases – e.g., sarcoidosis.
• Infections – chronic bacterial (e.g., staphylococcal) or fungal infections can precipitate a similar granulomatous reaction.
• Trauma or repeated pressure – especially on the shins (e.g., from sports or tight footwear).
• Medications – reports link certain drugs (e.g., interferon‑alpha, thalidomide) with NL‑like lesions.
• Hyperlipidaemia – elevated cholesterol or triglycerides may worsen microvascular health.
• Smoking – nicotine causes vasoconstriction, which can aggravate the vascular component of NL.
• Genetic predisposition – rare familial clusters suggest a hereditary component.

Associated Symptoms

Patients with necrobiosis lipoidica often notice additional skin changes or systemic signs:

• Itching or burning – especially when lesions are inflamed.
• Pain or tenderness – the plaque can become sore, particularly after pressure.
• Ulceration – breakdown of the atrophic centre may lead to non‑healing ulcers, which are prone to infection.
• Discoloration – a reddish or violaceous border may surround the yellow‑brown centre.
• Skin thinning – the central area can become parchment‑like and fragile.
• Changes in sensation – occasional numbness if nerves are compressed.
• Systemic clues – uncontrolled blood glucose, weight loss, or joint aches may hint at an underlying autoimmune or diabetic process.

When to See a Doctor

Because necrobiosis lipoidica can progress to ulceration and infection, early medical evaluation is important. Seek care promptly if you notice:

• New or enlarging shiny plaques on the legs, especially if they have a yellow‑brown hue.
• Persistent itching, burning, or pain that does not improve with simple measures.
• Signs of ulceration – a break in the skin, drainage, or a raw surface.
• Redness, warmth, or swelling around a lesion (possible infection).
• Any skin change that appears suddenly or spreads rapidly.
• Uncontrolled blood‑sugar levels or new‑onset diabetes symptoms.

Diagnosis

Diagnosing necrobiosis lipoidica involves a combination of clinical observation, patient history, and sometimes laboratory or pathology studies.

Clinical examination

• Visual inspection of the “apple‑jelly” plaque – translucency, yellow‑brown colour, and a raised, sometimes telangiectatic border.
• Palpation to assess thickness, tenderness, and the degree of atrophy.

Skin biopsy

A punch or excisional biopsy of the lesion’s edge provides histopathology that shows:

• Degeneration of collagen (necrobiosis) surrounded by granulomatous inflammation.
• Thickened blood‑vessel walls (plasma cell infiltrate) and lipid‑laden macrophages.

Laboratory testing

• Fasting blood glucose and HbA1c – to detect undiagnosed diabetes or assess control.
• Lipid profile – hyperlipidaemia can be a co‑factor.
• Autoantibody panel (ANA, RF, anti‑thyroid) if an autoimmune disorder is suspected.
• Screen for infections if ulceration is present (culture, Gram stain).

Imaging (rare)

In atypical cases, Doppler ultrasound can evaluate underlying vascular changes, but it is not routine.

Treatment Options

Treatment is aimed at reducing inflammation, promoting healing, and preventing complications. Because NL is chronic, many patients require long‑term management.

Topical therapies

• High‑potency corticosteroids (e.g., clobetasol 0.05 % ointment) – applied once or twice daily for 2–4 weeks, then tapered.
• Topical calcineurin inhibitors (tacrolimus 0.1 % or pimecrolimus) – useful for steroid‑sparing, especially on thin skin.
• Platelet‑rich plasma (PRP) or growth‑factor creams – emerging evidence suggests accelerated wound closure in ulcerated lesions [3].

Systemic medications

• Systemic corticosteroids – short courses for rapidly progressive disease.
• Antimalarial drugs (hydroxychloroquine 200–400 mg daily) – immunomodulatory effect, especially when associated with lupus.
• TNF‑α inhibitors (adalimumab, infliximab) – case series report improvement in refractory NL.
• Thalidomide – potent anti‑angiogenic agent but limited by neuropathy risk; reserved for severe cases.
• Mycophenolate mofetil or azathioprine – alternative immunosuppressants for patients who cannot tolerate steroids.

Procedural options

• Laser therapy – CO₂ or pulsed‑dye laser can reduce erythema and improve texture.
• Phototherapy (PUVA or UV‑B) – occasional benefit in early lesions.
• Skin grafting – considered when chronic ulceration fails to heal.

Wound‑care measures (for ulcerated lesions)

• Gentle debridement of necrotic tissue.
• Moist wound dressings (hydrocolloid, alginate, or silicone).
• Off‑loading pressure (special cushions, compression stockings).
• Systemic antibiotics if there are signs of infection (culture‑directed).

Adjunctive lifestyle measures

• Strict glycaemic control – the single most important factor for diabetic patients.
• Smoking cessation – improves microvascular health.
• Weight management and regular exercise to enhance circulation.
• Avoidance of trauma – protective padding for the shins during sports.

Prevention Tips

While NL cannot always be prevented, the risk of developing new lesions or worsening existing ones can be reduced:

• Maintain optimal blood‑sugar levels – aim for HbA1c < 7 % (individual targets may vary).
• Quit smoking – seek counseling, nicotine‑replacement, or prescription aids.
• Protect the skin – wear breathable, cushioned clothing; use knee pads if you engage in activities that stress the shins.
• Regular skin checks – examine legs weekly for new discoloration or ulceration, especially if you have diabetes.
• Manage lipid levels – diet, exercise, and medications as directed by your physician.
• Promptly treat infections – any cellulitis or fungal infection on the lower limbs should be evaluated early.
• Follow up with your dermatologist or endocrinologist at least annually, or sooner if lesions change.

Emergency Warning Signs

Key Take‑aways

• Apple‑jelly skin (necrobiosis lipoidica) is a rare, often diabetes‑related, granulomatous skin disease most commonly found on the shins.
• Early recognition and control of underlying risk factors (especially blood‑sugar and smoking) are essential to limit progression.
• Topical steroids, immunomodulatory drugs, and specialized wound care can improve most lesions; severe cases may require systemic therapy or procedural intervention.
• Watch for infection, ulceration, or rapidly changing lesions—these are emergency signs that require prompt professional care.

---

References:

1. Mayo Clinic. “Necrobiosis Lipoidica.” Updated 2023. Link
2. American Diabetes Association. “Skin Complications of Diabetes.” 2022. Link
3. J. Kim et al., “Platelet‑rich plasma for necrobiosis lipoidica ulcerations,” *Journal of Dermatologic Treatment*, 2021. DOI:10.1080/09546634.2021.1902179
4. CDC. “Guidelines for Wound Care in Diabetic Patients.” 2021. Link
5. Cleveland Clinic. “Necrobiosis Lipoidica – Symptoms & Treatments.” 2023. Link

```